News-Medical.Net on MSN
Novel treatment disrupts tumor immunosuppression in pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a five-year survival rate below 10%.
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a five-year survival rate below 10%.
News-Medical.Net on MSN
Tumor cells adapt and thrive in damaged parts of the pancreas
Pancreatic cancer is one of the most aggressive cancer types. A new study from Karolinska Institutet, in collaboration with ...
1don MSN
Tumor cells can exploit damaged tissue in the pancreas to create new environments for growth
Pancreatic cancer is an aggressive disease, and unlike many other cancers, survival rates have barely improved. Researchers ...
Truist analysts called the results "encouraging" while pointing out certain unknowns in the data. Immuneering plans to kick ...
For the first time, scientists have identified 27 bacteria and fungi living in our mouths that are implicated in the ...
A Cornell-led study has revealed how a deadly form of pancreatic cancer enters the bloodstream, solving a long-standing ...
(OS) observed at 9 months; standard of care benchmark is ~47% -- 53% progression-free survival (PFS) observed at 9 months; ...
Utidelone, previously received orphan drug designation from the FDA for the treatment of breast cancer brain metastases and gastric cancer. The U.S. Food and Drug Administration (FDA) has reportedly ...
Fermented stevia with banana leaf bacteria kills pancreatic cancer cells in lab tests. A compound called CAME triggers cell ...
Circulating tumor DNA (ctDNA), small pieces of DNA released from dying tumor cells into the bloodstream, can be easily and non-invasively identified and ex | Cancer ...
Middlesex County is inviting residents to lace up their sneakers and participate in the 2025 Annual Pancreatic Cancer Walk on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results